These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7920452

  • 21. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K, Sibug RM, De Kloet ER, Barthelmebs M, Grima M, Imbs JL, De Jong W.
    Eur J Pharmacol; 2002 Feb 02; 436(3):207-16. PubMed ID: 11858800
    [Abstract] [Full Text] [Related]

  • 22. Enhanced vascular responsiveness to Bay K 8644 in mineralocorticoid- and N-nitro arginine-induced hypertension.
    Watts SW, Finta KM, Lloyd MC, Storm DS, Webb RC.
    Blood Press; 1994 Sep 02; 3(5):340-8. PubMed ID: 7532526
    [Abstract] [Full Text] [Related]

  • 23. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q, Touyz RM, Schiffrin EL.
    J Hypertens; 2002 May 02; 20(5):899-907. PubMed ID: 12011651
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Altered vascular reactivity and KATP channel currents in vascular smooth muscle cells from deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Ghosh M, Hanna ST, Wang R, McNeill JR.
    J Cardiovasc Pharmacol; 2004 Nov 02; 44(5):525-31. PubMed ID: 15505488
    [Abstract] [Full Text] [Related]

  • 26. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Nov 02; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 27. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats.
    Nakano D, Itoh C, Ishii F, Kawanishi H, Takaoka M, Kiso Y, Tsuruoka N, Tanaka T, Matsumura Y.
    Biol Pharm Bull; 2003 Dec 02; 26(12):1701-5. PubMed ID: 14646174
    [Abstract] [Full Text] [Related]

  • 28. Glomerular thromboxane contributes to pressor response in deoxycorticosterone acetate-salt hypertension.
    Kosugi T, Ikeda T, Gomi T, Ushijima T, Okada J.
    Prostaglandins Leukot Essent Fatty Acids; 1998 Feb 02; 58(2):129-33. PubMed ID: 9578151
    [Abstract] [Full Text] [Related]

  • 29. Vascular changes in DOCA hypertension. Influence of a low protein diet.
    Moreland RS, Webb RC, Bohr DF.
    Hypertension; 1982 Feb 02; 4(5 Pt 2):III99-107. PubMed ID: 7106953
    [Abstract] [Full Text] [Related]

  • 30. Afferent arteriolar diameter in DOCA-salt and two-kidney one-clip hypertensive rats.
    Iversen BM, Mørkrid L, Ofstad J.
    Am J Physiol; 1983 Dec 02; 245(6):F755-62. PubMed ID: 6362430
    [Abstract] [Full Text] [Related]

  • 31. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats.
    Laurant P, Kantelip JP, Berthelot A.
    J Nutr; 1995 Apr 02; 125(4):830-41. PubMed ID: 7722684
    [Abstract] [Full Text] [Related]

  • 32. Naloxone attenuates development of hypertension in DOCA-salt hypertensive rats.
    Zhai SD, Malvin RL.
    Clin Exp Hypertens A; 1991 Apr 02; 13(1):133-42. PubMed ID: 2022070
    [Abstract] [Full Text] [Related]

  • 33. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H, Kondo K, Saruta T.
    Acta Endocrinol (Copenh); 1981 Aug 02; 97(4):525-32. PubMed ID: 7270008
    [Abstract] [Full Text] [Related]

  • 34. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
    Wenceslau CF, Rossoni LV.
    J Hypertens; 2014 Mar 02; 32(3):542-54. PubMed ID: 24309491
    [Abstract] [Full Text] [Related]

  • 35. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
    Nunes VW, Fortes ZB, Nigro D, Carvalho MH, Zorn TM, Scivoletto R.
    Gen Pharmacol; 2000 Feb 02; 34(2):117-25. PubMed ID: 10974419
    [Abstract] [Full Text] [Related]

  • 36. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS, Larivière R, Schiffrin EL.
    Hypertension; 1994 Aug 02; 24(2):183-8. PubMed ID: 8039842
    [Abstract] [Full Text] [Related]

  • 37. Effects of dietary fish oil or pectin on blood pressure and lipid metabolism in the DOCA-salt hypertensive rat.
    Bond V, Ordor O, Bruckner G, Webb P, Kotchen T, Tearney RJ, Adams RG.
    J Nutr; 1989 May 02; 119(5):813-7. PubMed ID: 2723830
    [Abstract] [Full Text] [Related]

  • 38. Chronic caffeine ingestion exacerbates 2-kidney, 1-clip hypertension and ameliorates deoxycorticosterone acetate-salt hypertension in rats.
    Choi KC, Lee J, Moon KH, Park KK, Kim SW, Kim NH.
    Nephron; 1993 May 02; 65(4):619-22. PubMed ID: 8302420
    [Abstract] [Full Text] [Related]

  • 39. Urinary excretion of digoxin-like factor (DLF) and ADH during DOCA-salt and Goldblatt 2 kidney-1 clip hypertension development.
    Vargas F, Casanova I, Haro JM, Luna JD, Garcia del Rio C.
    Horm Metab Res; 1990 Jun 02; 22(6):352-5. PubMed ID: 2199365
    [Abstract] [Full Text] [Related]

  • 40. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
    Robin S, Maupoil V, Laurant P, Jacqueson A, Berthelot A.
    Br J Nutr; 2004 Jun 02; 91(6):857-65. PubMed ID: 15182389
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.